Advances in clinical pulmonology are transforming the diagnosis, management, and long-term outcomes of patients with complex respiratory conditions. With an increasing burden of chronic respiratory diseases globally, clinical decision-making now demands integration of precision diagnostics, phenotype-specific therapies, and real-time monitoring tools. The role of multidisciplinary care is expanding, especially in managing conditions like pulmonary hypertension, interstitial lung diseases, and acute respiratory distress syndrome. Recent studies have emphasized the significance of early intervention strategies and individualized treatment protocols based on disease progression markers. The emergence of digital health tools, such as remote spirometry and AI-assisted radiologic analysis, is further refining clinical workflows. In addition, updated global guidelines for obstructive and restrictive lung diseases underscore a more nuanced approach to pharmacologic regimens and rehabilitation. Clinical Pulmonology stands at a pivotal intersection of evidence-based medicine, patient-centered care, and technological evolution—driving the next phase of respiratory healthcare delivery.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal
Title : Towards the experience and view of personalized and precision pulmonology: An option for clinicians, geneticists and caregivers to realize the potential of genomics informed lung cancer care to secure the individualized human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Opioid induced hypoventilation and sleep related hypoxemia in a patient on buprenorphine naloxone an underrecognized problem.
Anusha Devarajan, University of Vermont Medical Center, United States